Arkolith/Insider Trading/TXG/Form 4

Saxonov Serge

Chief Executive Officer, Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Dec 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2024Option exercise(M)12K$1.20$14K885K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2024Option exercise(M)12K—$067K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000554) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML